Lot's of folks ask me which broker I recommend and use and it's hands down Interactive Brokers. They've been in the game since 1977 and are a publicly listed company in the NYSE so you have trust and faith that they know what they're doing especially handling your hard earned money. This video is for all of y'all looking to get started with IBKR. You can use my referral link to get started and you can get up to a bonus of $200 worth of free stock to get you started! Please play it on 0.75 speed if the current speed is too fast for you to follow along. Also, PLEASE MAKE SURE YOU OPEN A CASH ACCOUNT. NOT MARGIN! Margin accounts are leveraged and basically you "borrow" money to control larger positions which if they go against you, you'll lose money immediately. Cash accounts are 1:1 meaning 1 dollar controls 1 single unit of stock. Flood this thread with questions if you get stuck and I'll be here to help!

☄️ This is the moment we've all been building toward! After 10 years of turning my own $217 into a $150K+ portfolio and helping hundreds of everyday people build life-changing wealth, I'm ready to share everything that got me here. While other "gurus" charge $2,000+ for generic advice, we are doing something revolutionary. I'm opening my EXACT GARP methodology — the same system I use to manage $1M+ in separately managed accounts — to a small group of serious members. 🎯 Why We are Doing This Now You've seen the results. If not look at my current results as of Friday the 26th of September 2025. You can see the winners like: - Royal Caribbean Cruises at $160.06 (now $324.53) - United Airlines at $48.11 (now $99.15) - Trip.com at $48.90 (now $75.71) - Sterling Infrastructure at $208.77 (now $338.44) But what you haven't seen is the **systematic process** behind these picks. The GARP framework that turns gut feelings into calculated wealth-building decisions. The research methodology that separates winners from hype traps. 💎 What Founding Members Get (Worth $3,600+ Value) ✅ 2 high quality stock pick recommendations every month($997 value) ✅ Weekly live market analysis calls ($200/month value) ✅ My real-time portfolio updates (priceless transparency) ✅ Direct access to me in exclusive member calls ✅ Priority email responses within 24 hours And there's more! ✅ Monthly stock deep-dives with buy/sell recommendations ✅ Market crash playbook (how I made money in 2022) ✅ Global opportunities across US, Europe & emerging markets ✅ Tax-efficient portfolio strategies for international investors ✅ Annual in-person meetup (first one: Nairobi 2026) ⚡️The Founding Member Opportunity **Regular Price:** $499.99/year **Founding Member Price:** $29.99/month *(locked in for life)* 🔥 What My Track Record Says - 10+ years of documented investing experience - $140K+ personal portfolio starting from $217 - $1M+ in assets under management - 361 community members in just 3 weeks

Hello guys , my experience funding my ibkr account through bank wire transfer has left me in thinking of using alternative channels due to high transaction’s costs. Swift transfers are just expensive especially if you are using a local banks. While the banks just tell you about their internal swift facilitation cost which range between kes 1500 - 2500 , the don’t mention about the international settlement fees which could range from 10 - 30 dollars or even more. Total charges from my past international swift transfers were almost 30% of the amount being transferred. The math doesn’t make sense . I have come across the wise app option though I'm skeptical as i have not used it before. Anyone who has used it before from kenya for international transfers? Is it a good options ? What other cheaper options are there?

Bristol-Myers Squibb is a leading biopharmaceutical company known for its strong cash generation and robust product portfolio. The company focuses on innovative medicines for serious diseases, maintaining stable margins and significant cash flow. Profitability - Return On Equity(ROE): 33.7% - Return On Asset(ROA): 6.3% - Return On Invested Capital(ROIC): 15.3% Bristol-Myers Squibb efficiently converts its assets into profits, maintaining strong profitability metrics. Cash Flow Strength - Free Cash Flow Yield: 15.26%(15.30B) - Low CapEx: Allows for substantial free cash flow - Dividends: Supported by strong cash flow The company consistently generates cash, supporting its dividend payments and strategic investments. Balance Sheet Health - Debt Levels: Managed effectively - Liquidity: Strong, ensuring operational flexibility Bristol-Myers Squibb maintains a healthy balance sheet, providing stability and resilience. Dividends - Annual Dividend: $2.28 per share - Yield: Approximately 3.5% - Payout Ratio: (83.49%) Sustainable, backed by cash flow The company offers a reliable dividend, appealing to income-focused investors. Business Model & Revenue - Innovative Medicines: Focus on oncology, immunology, and cardiovascular diseases - Global Reach: Extensive distribution network - Research & Development: Significant investment in pipeline development Bristol-Myers Squibb leverages its strong R&D capabilities to drive growth and maintain competitive advantage. Growth & Future Plans - Pipeline Expansion: Focus on high-potential therapeutic areas - Strategic Partnerships: Enhancing product offerings and market reach - Operational Efficiency: Continuous improvement initiatives The company is poised for steady growth, driven by its robust pipeline and strategic initiatives. Valuation (Attractive) - PE Ratio: (16.58) Competitive within the industry - EV/EBITDA: Reflects strong operational performance - Market Position: Valued for its innovation and growth potential

Happy new week Basquiater's. I hope everyone who owns a couple of stocks didn't freak out and sell when the market turned down last week. A reminder that as long as you stick to the fundamentals, the wild emotional swings of market downturns should be viewed as an opportunity to buy more shares of your companies AT A DISCOUNT. It's like going to the supermarket and finding everything on sale. When you find out that investing is just a psychological and mental fortitude game, you will never lose! How are your portfolios doing? Feel free to share in the comments, throw in a screenshot too! Anyway, here's your digest. 👨‍💻 Tech Leads Market Rally, Alphabet and Broadcom Surge U.S. equities rebounded sharply as optimism around AI and a possible December Fed rate cut sparked a rally. Alphabet jumped 6% after a strong AI model launch, and Broadcom soared over 11%, cementing tech’s leadership in the S&P 500 and Nasdaq rally. 📈 Nasdaq Posts Strongest Gain Since May; S&P 500 Up 1.5% The Nasdaq 100 surged 2.6% for its best day in more than six months, while the S&P 500 climbed 1.55%. The rally comes as investors speculate the recent tech-led selling may be bottoming, with sentiment improving on rate cut hopes. 🚘 Tesla Rallies on AI Chip News, Semiconductors Benefit Tesla rose nearly 7% after CEO Elon Musk touted advanced in-house AI chip capabilities. Other semiconductor and AI-centric firms such as Micron and AMD also gained 5-8% on hopes of ongoing AI spending. 💊 Novo Nordisk Tumbles on Alzheimer’s Drug Miss Novo Nordisk shares plunged more than 10% after its Alzheimer's trial with flagship semaglutide failed primary endpoints. The disappointment hit the health care sector but was offset in part by rotation back to tech. ₿ Bitcoin Stabilizes Above $87,000 After ETF Outflows and Technical Selling Bitcoin steadied above $87,000, rebounding from lows near $80,000 last week despite continued ETF outflows and technical pressure. Derivatives data and negative funding rates suggest a local bottom may be forming, with risk of a near-term short squeeze.